Invesco NASDAQ Future Gen 200 ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Invesco NASDAQ Future Gen 200 ETF QQQS
Morningstar’s Analysis QQQS
Will QQQS outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 7.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Newell Brands Inc | 0.82 | 178,587 | Consumer Defensive |
10x Genomics Inc Ordinary Shares - Class A | 0.80 | 175,652 | Healthcare |
Myriad Genetics Inc | 0.80 | 174,348 | Healthcare |
Helus Pharma Inc Ordinary Shares | 0.79 | 173,015 | Healthcare |
Rapid7 Inc | 0.74 | 162,409 | Technology |
Agenus Inc | 0.73 | 159,740 | Healthcare |
Groupon Inc | 0.72 | 157,933 | Communication Services |
QuidelOrtho Corp | 0.72 | 156,627 | Healthcare |
Q32 Bio Inc | 0.70 | 153,895 | Healthcare |
Akebia Therapeutics Inc | 0.70 | 153,482 | Healthcare |